Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma

• Үндсэн зохиолчид: Si Ni Li (Зохиогч), Xiaomin Wan (Зохиогч), Liu Bao Peng (Зохиогч), Ya Min Li (Зохиогч), Jian He Li (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2023-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Immune checkpoint inhibitors (ICIs) and targeted treatments have improved the health outcomes of patients with advanced melanoma. However, due to the high cost of novel therapies, it is crucial to evaluate their value by considering both effectiveness and cost. To compare the cos...